Radioactive iodine ablation therapy also known as radioiodine remnant ablation which improves survival rate of patients which affected by follicular or papillary thyroid cancer. According to WHO thyroid cancer is differentiated into papillary and follicular thyroid cancer. Abnormal cell or cancerous cell begin to grow in thyroid gland then Thyroid cancer occurs which excretes thyroid hormones excessively. Thyroid cancer is very uncommon type of cancer. Radioactive iodine also known as I-131 when taken into the body in any form such as Capsule or liquid form and concentrates in thyroid cells. Radioactive iodine ablation therapy can destroy the thyroid gland and any other thyroid cells.
Radioactive iodine ablation therapy is used to destroy any thyroid tissue which does not removed by surgery or to treat some types of thyroid cancer that have spread to lymph nodes and other parts of the body. Radioactive iodine ablation therapy accurately diagnose and treat thyroid cancer. Radioactive iodine ablation therapy are highly painless, effective and cosmetically alternative to surgery for selected cancers. Radioactive iodine ablation therapy destroy remaining thyroid cells after a thyroidectomy. Radioactive Iodine Ablation Therapy decreases the chance of developing a thyroid cancer.
The growth of Radioactive Iodine Ablation Therapy market is driven by rapidly increasing advancement of technology in radiation therapy segment in recent few years. Rising demand of Radioactive Iodine Ablation Therapy is due to increasing the prevalence rate of differentiated thyroid cancer and the increasing geriatric population. Increasing mortality & morbidity caused due to thyroid cancer and other thyroidism diseases is also a factor driving the rapid advancement of technology demand for Radioactive Iodine Ablation Therapy across the globe. The increasing awareness of research for such kind of Radioactive Iodine Ablation Therapy and the development of cost effective radioactive therapy are the important growth drivers increasing the demand of Radioactive Iodine Ablation Therapy market.
Limited availability of trained professionals & increment in the expressing side effects after the Radioactive Iodine Ablation Therapy restraints the growth of Radioactive Iodine Ablation Therapy market. Radioactive Iodine Ablation therapy is not used in some condition in which some cancer cells do not take up iodine, such as medullary and anaplastic thyroid cancers. Due to its increasing high demand, Radioactive Iodine Ablation Therapy market is expected grow for the forecast period.
The global Radioactive Iodine Ablation market is witnessing a fast growth due to increasing awareness among end user segment regarding healthcare. Radioactive Iodine Ablation market is driven by growing due to the increase in the prevalence rate of thyroid cancer.
The hospital segment generates highest revenue share in Radioactive Iodine Ablation Therapy market owning to more number of Radioactive Iodine Ablation whereas beta-based therapy & Gamma is anticipated to register highest growth rate over the forecast period. The key players in Radioactive Iodine Ablation market are focusing on geographical expansion to increase the business footprints.
On the basis of geography, the global acoustic puncture assist devices market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa.The North America market for Radioactive Iodine Ablation Therapy market holds the largest revenue share, due to rising awareness for health-care and owing to the increasing prevalence of cancer recorded in the U.S. and increasing preference of the novel therapies.
Europe Radioactive Iodine Ablation Therapy market is anticipated to grow substantially due growing number of players in the region and owing to increasing prevalence of disease and improved healthcare facilities. APAC is a fast-growing regional market for Radioactive Iodine Ablation Therapy due to having huge mass of people in this region. Raise in the Latin America and the Middle East and Africa is growing steadily. Latin America and Middle East & Africa are projected to exhibit slow growth in Radioactive Iodine Ablation Therapy market, owing to lack of awareness and high cost.
Examples of some of the key players provider present in the global Radioactive Iodine Ablation Therapy market are HealthTronics, Galil Medical Inc., Angiodynamics, Misonix Inc., Medtronic Plc., SonaCare Medical, Boston Scientific Corporation, Neuwave Medical Inc., EDAP TMS S.A. Covidien, Plc, Theranostic Treatment Services, Jubilant DraxImage, Cardinal Health, Inc., GE Healthcare Bracco Imaging S.p.A, Nordion, Inc., Bay among others.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The global Radioactive Iodine Ablation Therapy market is segmented on basis of application, technology, end user and geography.
Based on Application, the Radioactive Iodine Ablation market is segmented into
Based on Technology, the Radioactive Iodine Ablation market is segmented into
Based on End User, the Radioactive Iodine Ablation market is segmented into
Explore Similar Insights
Radioactive Iodine Ablation Therapy Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
